Summary of Study ST004035

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR002527. The data can be accessed directly via it's Project DOI: 10.21228/M80R9W This work is supported by NIH grant, U2C- DK119886. See: https://www.metabolomicsworkbench.org/about/howtocite.php

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files
Study IDST004035
Study TitleSerum Metabolites at Defined Stages of Liver Disease
Study SummaryThe goal of this study was to reveal serum metabolome differences at defined stages of liver disease from fatty liver to hepatocellular carcinoma. This study investigates serum metabolomic alterations in a mouse model of non-alcoholic steatohepatitis (NASH) and HCC) using the STAM (Streptozotocin and High-Fat Diet) model. Male mice were administered streptozotocin (STZ) shortly after birth and subsequently fed a high-fat diet to induce liver disease progression resembling human NASH and HCC. Blood samples were collected at a defined disease stage , and serum was isolated for untargeted metabolomic profiling. Using LC-MS, we profiled the serum metabolites to identify disease-associated metabolic signatures. The study parameters include treatment condition (control vs. STAM), sample collection time (e.g., ZT8), and serum metabolite intensity values. Analysis revealed significant changes in pathways related to lipid metabolism, bile acid biosynthesis, amino acid metabolism, and energy homeostasis in the STAM group compared to controls. These metabolic alterations may reflect the systemic metabolic disturbances associated with NASH progression and HCC risk, providing potential biomarkers and therapeutic targets.
Institute
University of Texas Health Science Center at Houston
DepartmentIMM
LaboratoryMahan Lab
Last NameFekry
First NameBaharan
AddressThe Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (IMM), 1825 Pressler St, Houston TX 77030, USA.
EmailBaharan.Fekry@uth.tmc.edu
Phone18434693199
Submit Date2025-07-02
Analysis Type DetailLC-MS
Release Date2025-07-15
Release Version1
Baharan Fekry Baharan Fekry
https://dx.doi.org/10.21228/M80R9W
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Subject:

Subject ID:SU004181
Subject Type:Mammal
Subject Species:Mus musculus
Taxonomy ID:10090
  logo